Targeting of the CD161 inhibitory receptor enhances T-cell–mediated immunity against hematological malignancies

Autor: Alvarez Calderon, Francesca, Kang, Byong H., Kyrysyuk, Oleksandr, Zheng, Shiwei, Wang, Hao, Mathewson, Nathan D., Luoma, Adrienne M., Ning, Xiaohan, Pyrdol, Jason, Cao, Xuan, Suvà, Mario L., Yuan, Guo-Cheng, Wittrup, K. Dane, Wucherpfennig, Kai W.
Zdroj: In Blood 21 March 2024 143(12):1124-1138
Databáze: ScienceDirect